← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

#	Name	Funds holding	Growth	Growth %	Fund value
1	1 Pfizer PFE $168B	2,526	+202	+9%	$157B
2	2 Amgen AMGN $235B	2,108	+224	+12%	$110B
3	3 Eli Lilly LLY $1.12T	1,673	+148	+10%	$98.1B
4	4 Becton Dickinson BDX $52.8B	1,472	+69	+5%	$63.1B
5	5 McKesson MCK $116B	864	+25	+3%	$21.6B
6	6 Conagra Brands CAG $6.77B	723	+50	+7%	$14.5B
7	7 Regeneron Pharmaceuticals REGN $82B	703	+70	+11%	$27.7B
8	8 Lamb Weston LW $7.47B	646	+44	+7%	$10.7B
9	9 Novo Nordisk NVO $173B	640	+76	+13%	$9.91B
10	10 AstraZeneca AZN $259B	635	+79	+14%	$22.3B
11	11 ResMed RMD $34.1B	560	+32	+6%	$15.1B
12	12 DaVita DVA $12.1B	453	+37	+9%	$8.8B
13	13 West Pharmaceutical WST $27B	445	+39	+10%	$10.2B
14	14 Teva Pharmaceutical Industries Limited TEVA $47.9B	437	+9	+2%	$5.76B
15	15 DELISTED CATALENT, INC. CTLT	288	-10	-3%	$8.43B
16	16 DELISTED WW International WW	248	+11	+5%	$2.22B
17	ARNA 17 DELISTED Arena Pharmaceuticals Inc ARNA	226	-4	-2%	$1.92B
18	18 Medifast MED $135M	219	-20	-8%	$1.46B
19	19 Herbalife HLF $1.53B	215	+19	+10%	$5.97B
20	20 Opko Health OPK $1.2B	199	+12	+6%	$259M
21	21 Tootsie Roll Industries TR $2.88B	193	+1	+0.5%	$539M
22	TWNK 22 DELISTED Hostess Brands, Inc. Class A Common Stock TWNK	189	+13	+7%	$2.05B
23	23 Accendra Health ACH $20.1M	180	+5	+3%	$295M
24	24 Fresenius Medical Care FMS $11.8B	171	+10	+6%	$357M
25	25 Inspire Medical Systems INSP $2.03B	171	+16	+10%	$1.65B